NCT01997918View on ClinicalTrials.gov

Secondary Haplo HSCT for Relapse After Initial Allogeneic HSCT

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 30, 2017

Study Completion Date

December 30, 2017

Conditions
Relapse of Hematological Malignancies
All Listed Sponsors
collaborator

Ludwig-Maximilians - University of Munich

OTHER

collaborator

University Hospital Augsburg

OTHER

lead

University Hospital Tuebingen

OTHER

NCT01997918 - Secondary Haplo HSCT for Relapse After Initial Allogeneic HSCT | Biotech Hunter | Biotech Hunter